TruScreen Group Company Description

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally.

The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time.

The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020.

TruScreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.

TruScreen Group Limited

Country	New Zealand
Founded	2013
Industry	Medical Devices
Sector	Healthcare
CEO	Martin Dillon

Contact Details

Address: Equitable House Auckland, 1010 New Zealand
Phone	61 2 8999 3896
Website	truscreen.com

Stock Details

Ticker Symbol	TRU
Exchange	New Zealand Stock Exchange
Fiscal Year	April - March
Reporting Currency	NZD
ISIN Number	NZTRUE0001S7
SIC Code	3845

Key Executives

Name	Position
Martin Dillon	Chief Executive Officer
Guy Robertson	Chief Financial Officer